MeSH tree: D12.776.631.650.300.001
A recent Northwestern Medicine study has identified novel neural circuits modulated by the diabetes and obesity-management drugs semaglutide and tirzepatide that help suppress appetite, according to findings published in ...
Oct 23, 2025
0
19
Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says.
Oct 21, 2025
0
18
There's mounting evidence that popular drugs prescribed for diabetes management and weight loss—better known by trade names like Ozempic and Wegovy—could be effective in reducing alcohol use.
Oct 15, 2025
0
41
About 1 in 3 Australian adults (32%) has a body-mass index (BMI) of 30 or above. A further 34% has a BMI of 25 or above.
Oct 14, 2025
0
9
Semaglutide or tirzepatide should be the first line treatment for people living with obesity and most of its complications, according to a new framework for the pharmacological treatment of obesity and its complications from ...
Oct 2, 2025
0
40
Weight loss treatments, including medication and surgical procedures, may help lower the risk of obesity-related cancers in people with obesity and type 2 diabetes, a new study shows.
Sep 26, 2025
0
13
A new Penn Nursing study suggests that the weight-loss drug tirzepatide may cause fewer side effects like nausea and vomiting than the drug semaglutide. This research, published in Science Advances, was conducted using preclinical ...
Sep 26, 2025
0
38
New research shows that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood sugar control and weight loss in children and adolescents with type 2 diabetes aged 10–17 years whose ...
Sep 18, 2025
0
16
Federal health officials are cracking down on telehealth companies' promotion of unapproved versions of prescription drugs, including popular weight loss medications.
Sep 17, 2025
0
13
A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs), semaglutide and tirzepatide, for patients with osteoarthritis and obesity compared with usual ...
Sep 15, 2025
0
31
